High-Dose Interleukin-2 Effective in mRCC Pre-Treated with VEGF-Targeted Therapies (video)

European Society for Medical Oncology

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.